The potential usage of caffeic acid phenethyl ester (CAPE) against chemotherapy-induced and radiotherapy-induced toxicity

Cell Biochemistry and Function

Volumn 30, Issue 5, 2012, Pages 438-443

  Akyol, Sumeyya ^a   Ginis, Zeynep ^b   Armutcu, Ferah ^a   Ozturk, Gulfer ^b   Yigitoglu, M Ramazan ^a   Akyol, Omer ^c,d  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^b DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d Ankara Branch of Council of Forensic Medicine   (Turkey)

Author keywords

Antineoplastic; Caffeic acid phenethyl ester (CAPE); Cancer; Side effect; Treatment

Indexed keywords

ADENOSINE DEAMINASE; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CAFFEIC ACID PHENETHYL ESTER; CATALASE; CISPLATIN; CREATININE; CYTARABINE; DOXORUBICIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; METHOTREXATE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TAMOXIFEN; TUMOR NECROSIS FACTOR ALPHA; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARDIOTOXICITY; CELL GROWTH; CELL VIABILITY; CHEMOTHERAPY INDUCED TOXICITY; CHROMOSOME ABERRATION; ENZYME ACTIVITY; HEART PROTECTION; IN VITRO STUDY; IN VIVO STUDY; LIVER TOXICITY; LUNG FIBROSIS; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; OTOTOXICITY; PREMEDICATION; PRIORITY JOURNAL; RADIOTHERAPY INDUCED TOXICITY; TOXICITY; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAFFEIC ACIDS; NEOPLASMS, EXPERIMENTAL; PHENYLETHYL ALCOHOL;

ANIMALIA; APIS MELLIFERA;

EID: 84863306204     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2817     Document Type: Article

References (42)

1. Sud'ina GF, Mirzoeva OK, Pushkareva MA, et al. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 1993; 329: 21-24.
2. Wang X, Pang J, Maffucci JA, et al. Pharmacokinetics of caffeic acid phenethyl ester and its catechol-ring fluorinated derivative following intravenous administration to rats. Biopharm Drug Dispos 2009; 30: 221-228.
3. Celli N, Dragani LK, Murzilli S, et al. In vitro and in vivo stability of caffeic acid phenethyl ester, a bioactive compound of propolis. J Agric Food Chem 2007; 55: 3398-3407.
4. Kumazawa S, Ahn MR, Fujimoto T, et al. Radical-scavenging activity and phenolic constituents of propolis from different regions of Argentina. Nat Prod Res 2010; 24: 804-812.
5. Chen HC, Chen JH, Chang C, et al. Optimization of ultrasound-accelerated synthesis of enzymatic caffeic acid phenethyl ester by response surface methodology. Ultrason Sonochem 2011; 18: 455-459.
6. Chen HC, Ju HY, Twu YK, et al. Optimized enzymatic synthesis of caffeic acid phenethyl ester by RSM. N Biotechnol 2010; 27: 89-93.
7. Kurata A, Kitamura Y, Irie S, et al. Enzymatic synthesis of caffeic acid phenethyl ester analogues in ionic liquid. J Biotechnol 2010; 148: 133-138.
8. Yagmurca M, Erdogan H, Iraz M, et al. Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. Clin Chim Acta 2004; 348: 27-34.
9. Chlopcikova S, Psotova A, Miketova P, et al. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes part II. Caffeic, chlorogenic and rosmarinic acids. Phytother Res 2004; 18: 408-413.
10. Fadillioglu E, Oztas E, Erdogan H, et al. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats. J Appl Toxicol 2004; 24: 47-52.
11. Fadillioglu E, Erdogan H, Iraz M, et al. Effects of caffeic acid phenethyl ester against doxorubicin-induced neuronal oxidant injury. Neurosci Res Commun 2003; 33: 132-138.
12. Lin YH, Chiu JH, Tseng WS, et al. Antiproliferation and radiosensitization of caffeic acid phenethyl ester on human medulloblastoma cells. Cancer Chemother Pharmacol 2006; 57: 525-532.
13. Ozen S, Akyol O, Iraz M, et al. Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats. J Appl Toxicol 2004; 24: 27-35.
14. Yilmaz HR, Uz E, Altunbasak A, et al. Anticlastogenic effect of caffeic acid phenethyl ester on cisplatin-induced chromosome aberrations in rat bone marrow cells. Toxicol Ind Health 2010; 26: 33-37.
15. Iraz M, Ozerol E, Gulec M, et al. Protective effect of caffeic acid phenethyl ester (CAPE) administration on cisplatin-induced oxidative damage to liver in rat. Cell Biochem Funct 2006; 24: 357-361.
16. Yilmaz HR, Sogut S, Ozyurt B, et al. The activities of liver adenosine deaminase, xanthine oxidase, catalase, superoxide dismutase enzymes and the levels of malondialdehyde and nitric oxide after cisplatin toxicity in rats: protective effect of caffeic acid phenethyl ester. Toxicol Ind Health 2005; 21: 67-73.
17. Kizilay A, Kalcioglu MT, Ozerol E, et al. Caffeic acid phenethyl ester ameliorated ototoxicity induced by cisplatin in rats. J Chemother 2004; 16: 381-387.
18. Van't Land B, Blijlevens NMA, Marteijn J, et al. Role of curcumin and the inhibition of NF-kappa B in the onset of chemotherapy-induced mucosal barrier injury. Leukemia 2004; 18: 276-284.
19. Uzar E, Sahin O, Koyuncuoglu HR, et al. The activity of adenosine deaminase and the level of nitric oxide in spinal cord of methotrexate administered rats: Protective effect of caffeic acid phenethyl ester. Toxicology 2006; 218: 125-133.
20. Oktem F, Yilmaz HR, Ozguner F, et al. Methotrexate-induced renal oxidative stress in rats: the role of a novel antioxidant caffeic acid phenethyl ester. Toxicol Ind Health 2006; 22: 241-247.
21. Uzar E, Koyuncuoglu HR, Uz E, et al. The activities of antioxidant enzymes and the level of malondialdehyde in cerebellum of rats subjected to methotrexate: protective effect of caffeic acid phenethyl ester. Mol Cell Biochem 2006; 291: 63-68.
22. Armagan A, Uzar E, Uz E, et al. Caffeic acid phenethyl ester modulates methotrexate-induced oxidative stress in testes of rat. Hum Exp Toxicol 2008; 27: 547-552.
23. Uz E, Oktem F, Yilmaz HR, et al. The activities of purine-catabolizing enzymes and the level of nitric oxide in rat kidneys subjected to methotrexate: protective effect of caffeic acid phenethyl ester. Mol Cell Biochem 2005; 277: 165-170.
24. Cakir T, Ozkan E, Dulundu E, et al. Caffeic acid phenethyl ester (CAPE) prevents methotrexate-induced hepatorenal oxidative injury in rats. J Pharm Pharmacol 2011; 63: 1566-1571.
25. Ozyurt H, Sogut S, Yildirim Z, et al. Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats. Clin Chim Acta 2004; 339: 65-75.
26. Albukhari AA, Gashlan HM, El-Beshbishy HA, et al. Caffeic acid phenethyl ester protects against tamoxifen-induced hepatotoxicity in rats. Food Chem Toxicol 2009; 47: 1689-1695.
27. Linard C, Marquette C, Mathieu J, et al. Acute induction of inflammatory cytokine expression after gamma-irradiation in the rat: effect of an NF-kappaB inhibitor. Int J Radiat Oncol Biol Phys 2004; 58: 427-434.
28. Yildiz OG, Soyuer S, Saraymen R, et al. Protective effects of caffeic acid phenethyl ester on radiation induced lung injury in rats. Clin Invest Med 2008; 31: E242-E247.
29. Lee YY, Kao CL, Tsai PH, et al. Caffeic acid phenethyl ester preferentially enhanced radiosensitizing and increased oxidative stress in medulloblastoma cell line. Childs Nerv Syst 2008; 24: 987-994.
30. Gremy O, Benderitter M, Linard C. Caffeic acid phenethyl ester modifies the Th1/Th2 balance in ileal mucosa after gamma-irradiation in the rat by modulating the cytokine pattern. World J Gastroenterol 2006; 12: 4996-5004.
31. Chen MF, Keng PC, Lin PY, et al. Caffeic acid phenethyl ester decreases acute pneumonitis after irradiation in vitro and in vivo. BMC Cancer 2005; 5: 158.
32. Chen YJ, Liao HF, Tsai TH, et al. Caffeic acid phenethyl ester preferentially sensitizes CT26 colorectal adenocarcinoma to ionizing radiation without affecting bone marrow radioresponse. Int J Radiat Oncol Biol Phys 2005; 63: 1252-1261.
33. Chen MF, Wu CT, Chen YJ, et al. Cell killing and radiosensitization by caffeic acid phenethyl ester (CAPE) in lung cancer cells. J Radiat Res (Tokyo) 2004; 45: 253-260.
34. Rahman I, MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med 2000; 28: 1405-1420.
35. Wang SH, Chen CS, Huang SH, et al. Hydrophilic ester-bearing chlorogenic acid binds to a novel domain to inhibit xanthine oxidase. Planta Med 2009; 75: 1237-1240.
36. Yoshizumi K, Nishioka N, Tsuji T. The xanthine oxidase inhibitory activity and hypouricemia effect of the propolis in rats. Yakugaku Zasshi-J Pharmaceut Soc Japan 2005; 125: 315-321.
37. Basini G, Baioni L, Bussolati S, et al. Antiangiogenic properties of an unusual benzo[k, l]xanthene lignan derived from CAPE (caffeic acid phenethyl ester). Invest New Drugs 2012; 30: 186-190.
38. Hwang HJ, Park HJ, Chung HJ, et al. Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells. J Nutr Biochem 2006; 17: 356-362.
39. Wang T, Chen LX, Wu WM, et al. Potential cytoprotection: antioxidant defence by caffeic acid phenethyl ester against free radical-induced damage of lipids, DNA, and proteins. Can J Physiol Pharmacol 2008; 86: 279-287.
40. Nomura M, Kaji A, Ma W, et al. Suppression of cell transformation and induction of apoptosis by caffeic acid phenethyl ester. Mol Carcinog 2001; 31: 83-89.
41. Colburn NH, Wendel EJ, Abruzzo G. Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: mitogen-resistant variants are sensitive to promotion. Proc Natl Acad Sci U S A 1981; 78: 6912-6916.
42. Garg AK, Buchholz TA, Aggarwal BB. Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal 2005; 7: 1630-1647.